(Q48459476)

11 February 2018

title

Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial. (English)

1 reference

11 February 2018

0 references

0 references

Andrey Scripnikov

1

1 reference

11 February 2018

Alexander Khomenko

series ordinal

2

1 reference

11 February 2018

Oleksandr Napryeyenko

series ordinal

3

1 reference

11 February 2018

GINDEM-NP Study Group

series ordinal

4

1 reference

11 February 2018

publication date

1 January 2007

1 reference

11 February 2018

Wiener Medizinische Wochenschrift

published in

1 reference

11 February 2018

volume

157

1 reference

11 February 2018

issue

13-14

1 reference

11 February 2018

page(s)

295-300

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s10354-007-0427-5

exact match

0 references

cites work

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0427-5

Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0427-5

The Ginkgo biloba extract, EGb761, increases synaptosomal uptake of 5-hydroxytryptamine: in-vitro and ex-vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0427-5

Demonstration of the "anti-stress" activity of an extract of Ginkgo biloba (EGb 761) using a discrimination learning task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0427-5

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0427-5

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0427-5

Clock drawing in Alzheimer's disease. A novel measure of dementia severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0427-5

A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0427-5

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0427-5

The spectrum of behavioral changes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0427-5

The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-007-0427-5

The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.

21 January 2018

1 reference

12 December 2020

Prevalence and correlates of behavioral and psychiatric symptoms in community-dwelling elders with dementia or mild cognitive impairment: the Memory and Medical Care Study.

1 reference

12 December 2020

Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761

1 reference

12 December 2020

A prospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia

1 reference

12 December 2020

Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial

1 reference

12 December 2020

Factor structure and scoring of the SKT test battery.

1 reference

12 December 2020

Comorbid psychosocial symptoms and quality of life in patients with dementia

1 reference

12 December 2020

Reduction of rise in blood pressure and cortisol release during stress by Ginkgo biloba extract (EGb 761) in healthy volunteers.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.

1 reference

12 December 2020

Influence of behavioral symptoms on rates of institutionalization for persons with Alzheimer's disease.

1 reference

12 December 2020

Behavioural and psychological symptoms of dementia (BPSD): effects of EGb 761

1 reference

12 December 2020

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

1 reference

12 December 2020

Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.

1 reference

12 December 2020

Determinants of costs of care for patients with Alzheimer's disease

1 reference

12 December 2020

Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761).

1 reference

12 December 2020

One-year risk of institutionalization in demented outpatients with caretaking relatives.

1 reference

12 December 2020

Effect of chronic administration of Ginkgo biloba extract or Ginkgolide on the hypothalamic-pituitary-adrenal axis in the rat.

1 reference

12 December 2020

The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

The TE4D-Cog: a new test for detecting early dementia in English-speaking populations.

1 reference

12 December 2020

10.1007/S10354-007-0427-5

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018